Journal of Internal Medicine
Wiley · GB · ISSN 09546820
动向摘要
Citation influence per paper has softened recently.
Field-weighted citation impact moved from 6.52 to 3.57. If you need high citedness for evaluation, consider this trend when choosing a venue. The share of top-10% cited papers moved from 43.2% to 38.0%. Expect a slightly lower chance of landing among the most-cited papers from this journal now. Liver Disease Diagnosis and Treatment rose from 3.5% to 10.2% of what the journal runs. Submitters working on liver disease diagnosis or treatment may find stronger topical fit at present. Recent titles increasingly carry steatotic · transthyretin · statin · cardiometabolic · cohort. If your title uses those emerging terms, your work may align with current editorial attention.
引用指标
基于 Scopus 与 OpenAlex 引用图谱。本站不提供 Clarivate 的 JCR 影响因子。
发文量与被引表现
发文量增长时被引表现是否同步。
主题变化
对比近 24 个月(2024-09 – 2026-08)与此前 24 个月(2022-09 – 2024-08)的占比。
- Liver Disease Diagnosis and Treatment3.5%→10.2%+6.7%p此前近期
- Atrial Fibrillation Management and Outcomes0.0%→5.6%+5.6%p此前近期
- Intensive Care Unit Cognitive Disorders0.0%→4.6%+4.6%p此前近期
- Blood Pressure and Hypertension Studies3.5%→7.4%+3.9%p此前近期
- Amyloidosis: Diagnosis, Treatment, Outcomes0.0%→3.7%+3.7%p此前近期
- Long-Term Effects of COVID-1910.4%→0.0%−10.4%p此前近期
- Healthcare Systems and Public Health7.0%→0.0%−7.0%p此前近期
- SARS-CoV-2 and COVID-19 Research5.2%→0.0%−5.2%p此前近期
- Adrenal Hormones and Disorders4.3%→0.0%−4.3%p此前近期
- Vitamin D Research Studies4.3%→0.0%−4.3%p此前近期
近期高频术语
近期论文标题中相较以往显著增加的表述。
作者国家构成
将近 24 个月(2024-09 – 2026-08)与此前 24 个月(2022-09 – 2024-08)并列显示。
- SE26.6%→28.9%+2.3%p此前近期
- US21.7%→20.9%−0.8%p此前近期
- IT8.2%→11.0%+2.7%p此前近期
- GB11.8%→9.3%−2.5%p此前近期
- CN9.9%→8.3%−1.6%p此前近期
- DE8.6%→8.0%−0.6%p此前近期
机构发文 Top 5
2018 – 2026 期间在该期刊发表论文的前 5 家机构。
近期发表论文
19按发表日期最新的 19 篇,并非全部。
高被引论文
202018 – 2026 期间被引最高的 20 篇。
相似期刊
数据截至 2026-09-05